Surgery in the age of biologics-Reference-Cited by-同舟云学术

Surgery in the age of biologics

Published:2019-03-11 Issue:2 Volume:7 Page:77-90
ISSN:2052-0034
Container-title:Gastroenterology Report
language:en
Short-container-title:

Author:

Wong Daniel J¹,Roth Eve M¹,Feuerstein Joseph D²,Poylin Vitaliy Y¹

Affiliation:

1. Department of Surgery, Division of Colon & Rectum Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

2. Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology

Link

http://academic.oup.com/gastro/article-pdf/7/2/77/28302547/goz004.pdf

Reference154 articles.

1. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey;Gunnarsson;Dig Dis Sci,2012

2. The future of IBD therapy: where are we and where should we go next?;Mao;Dig Dis,2016

3. Direct health care costs of Crohn’s disease and ulcerative colitis in US children and adults;Kappelman;Gastroenterology,2008

4. Course of ulcerative colitis: analysis of changes in disease activity over years;Langholz;Gastroenterology,1994

5. Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?;Rizzo;World J Gastroenterol,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New anti-mesenteric delta-shaped stapled anastomosis: Technical report with short-term postoperative outcomes in patients with Crohn’s disease;World Journal of Gastrointestinal Surgery;2024-08-27

2. Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease;Gut Microbes;2024-08-21

3. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

4. Global geoepidemiology of gastrointestinal surgery rates in Crohn’s disease;World Journal of Gastrointestinal Surgery;2024-06-27

5. Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease;2024-05-10